Meda to acquire US speciality pharma firm for $350 million
This article was originally published in Scrip
Executive Summary
Meda of Sweden is to acquire the US speciality pharma company Alaven Pharmaceutical to enhance its US marketing capabilities and expand its therapeutic focus to include both gastroenterology and women's health, areas it already operates in outside of the US.